Related Experiment Videos
Treatment options for the pharmacological therapy of neonatal meningitis
1Division of Clinical Pharmacy, University of Texas College of Pharmacy, Austin.
Abstract:
Neonatal bacterial meningitis has a relatively low incidence in developed countries, but continues to cause morbidity and mortality despite advances in antimicrobial therapy. Bacterial pathogens commonly associated with neonatal meningitis include Group B streptococci, Escherichia coli K1 and other coliforms, Listeria monocytogenes and staphylococci. As it can be difficult to differentiate meningitis from septicaemia in neonates, empirical antibiotic therapy should be effective for both. Selection of an empirical antibiotic regimen should be based on: (a) bacterial prevalence and susceptibility; (b) drug characteristics; (c) postnatal age at the onset of disease; and (d) patient-specific factors. A penicillin in combination with an aminoglycoside or cefotaxime is commonly used in empirical therapies. The increased risk of staphylococcal infection in older neonates requires consideration of an antistaphylococcal antibiotic in the empirical therapy regimen. Once a causative organism has been identified, antimicrobial therapy should be directed towards that pathogen. Duration of therapy remains empirical, but should be at least 7 days for documented bacterial meningitis. Viral meningitis continues to have a high mortality despite the availability of antiviral agents. Adjunctive therapies may further reduce the morbidity and mortality of meningitis. While most of these therapeutic options have not been investigated in neonates, they may prove to be of benefit in the future. Anti-inflammatory agents, such as glucocorticoids, nonsteroidal anti-inflammatory agents and immunoglobulin, may modulate the inflammatory response of a meningeal infection. Other possible therapies in neonatal meningitis include cerebral blood flow modulators and disease prevention with maternal vaccines and perinatal antibiotics. Practical aspects of drug therapy such as route of administration and serum drug concentration monitoring can improve both drug therapy and patient outcome. While antibiotics have greatly improved the treatment outcome of neonatal meningitis, it is clear that additional intervention will be required to increase cure rates and reduce sequelae.
Insights
Neonatal bacterial meningitis treatment involves selecting empirical antibiotics based on pathogen prevalence and patient factors. Directed therapy and adjunctive treatments are crucial for improving outcomes and reducing long-term effects.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Pharmacology
Background:
- Neonatal bacterial meningitis, though rare in developed nations, poses significant morbidity and mortality risks.
- Common pathogens include Group B Streptococcus, E. coli K1, and Staphylococcus species.
- Differentiating meningitis from sepsis in neonates necessitates broad-spectrum empirical antibiotic coverage.
Purpose of the Study:
- To review current strategies for empirical and directed antibiotic therapy in neonatal meningitis.
- To discuss adjunctive therapies and preventive measures for improving patient outcomes.
- To highlight practical considerations in drug administration and monitoring.
Main Methods:
- Literature review of current guidelines and research on neonatal meningitis treatment.
- Analysis of factors influencing empirical antibiotic selection.
- Evaluation of potential adjunctive therapies and preventive strategies.
Main Results:
- Empirical therapy often combines penicillin with aminoglycosides or cefotaxime, adjusted for age and suspected pathogens.
- Antistaphylococcal agents are considered for older neonates.
- Directed therapy post-identification of the pathogen is recommended, with a minimum 7-day duration.
- Adjunctive therapies like anti-inflammatories and disease prevention strategies show promise.
Conclusions:
- Antibiotic therapy has improved neonatal meningitis outcomes, but further interventions are needed.
- Optimizing drug administration and monitoring serum concentrations enhance treatment efficacy.
- Future research into adjunctive therapies and preventive measures is warranted to further reduce mortality and sequelae.